Skip to content
Equity Capital Market
  • Privacy Policy
  • Start Here
  • Research
    • LPTH case study
    • PLUG case study
    • STDN case study
  • IPO & Public Offerings
  • Economy & Macro
  • Latest
  • Stock Market
  • Market Education
  • Energy & Commodities
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact
  • Guides
    • Options guides
    • Bonds & Rates guides
    • Valuation guides
    • IPOs guides

precision medicine group

McKesson to Buy Precision Medicine Group for $2.25B

October 27, 2026August 25, 2026 by Bruno M.
McKesson to Buy Precision Medicine Group for $2.25B

McKesson unveiled a $2.25B deal for Precision Medicine Group, doubling down on its fastest-growing segment: Oncology & Multispecialty.

Categories Stock Market Tags biomarker, capital markets, mckesson, oncology services, precision medicine group

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Credit Card APR Explained: Average Daily Balance and DPR Math
  • Southern Co Prices $1.75B Equity Units at 8.625% Yield
  • Cisco Q1 FY27: Record $18.5B Sales as AI Networking Targets $9B
  • Mortgage APR vs. Interest Rate: How Loan Fees Work
  • American Tower Reopens $1.5B Senior Notes Across Three Tranches

Subscribe to Our Newsletter

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

  • Privacy Policy
  • Editorial Policy
  • Corrections Policy
  • Financial Disclaimer
  • Contact
  • About Bruno M.
  • Investor Tools
© 2026 Equity Capital Market • Built with GeneratePress